| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/22/2010 | US20100183600 RAF Inhibitors and Their Uses |
| 07/22/2010 | US20100183598 Methods of treating cardiovascular disorders |
| 07/22/2010 | US20100183597 Drak2 expression is associated with diabetes |
| 07/22/2010 | US20100183593 Gene Polymorphisms Predictive for Dual TKI Therapy |
| 07/22/2010 | US20100183591 Modulation of nkg2d |
| 07/22/2010 | US20100183587 Therapeutic Compositions for Treatment of Corneal Disorders |
| 07/22/2010 | US20100183584 Conformation and activity of gbeta5 complexes |
| 07/22/2010 | US20100183581 Compositions and Methods for Modulating Blood-Brain Barrier Transport |
| 07/22/2010 | US20100183580 Treatment of pigs for reducing the feed conversion ratio or increasing the growth rate |
| 07/22/2010 | US20100183579 Memory enhancing protein |
| 07/22/2010 | US20100183577 Enzyme replacement therapy for treating lysosomal storage diseases |
| 07/22/2010 | US20100183573 membrane polypeptide for use in designing therapeutic for proliferative, inflammatory, skin, arthritic, cardiovascular and autoimmune disorders; cancer, immunological-related, blood-related and skin-related disorders |
| 07/22/2010 | US20100183569 Porous composite material, preparation process thereof and use to realize tissue engineering devices |
| 07/22/2010 | US20100183567 Novel Mammalian Multipotent Stem Cells and Compositions, Methods of Preparation and Methods of Administration Thereof |
| 07/22/2010 | US20100183564 Compounds that expand hematopoietic stem cells |
| 07/22/2010 | US20100183560 Angiogenesis-modulating compositions and uses |
| 07/22/2010 | US20100183556 Recombinant expression vector system for variants of coagulation factor VIII and von Willebrand factor |
| 07/22/2010 | US20100183553 Composition and Methods for Affecting Metallocorrinoid Uptake |
| 07/22/2010 | US20100183552 1-[2-amino-3-(substituted alkyl)-3h-benzimidazolylmethyl]-3-substituted-1,3-dihydro-benzoimidazol-2-ones and structural analogs |
| 07/22/2010 | US20100183550 Benzothienopyridines For Use As Inhibitors Of EG5 Kinesin |
| 07/22/2010 | US20100183548 Tweak receptor |
| 07/22/2010 | US20100183537 Stable and bioavailable compositions of isomers of carotenoids for skin and hair |
| 07/22/2010 | US20100183531 Stable soluble salts of phenylbenzimidazole sulfonic acid at phs at or below 7.0 |
| 07/22/2010 | US20100183519 Topical Poloxamer Formulations for Enhancing Microvascular Flow: Compositions and Uses Thereof |
| 07/22/2010 | US20100183517 Peptidomimetic Inhibitors Of PSMA, Compounds Comprising Them, And Methods Of Use |
| 07/22/2010 | US20100183513 N-(methyl) -1h-pyrazol-3-amine, n-(methyl)-pyridin-2-amine and n-(methyl)-thiazol-2-amine derivatives for the treatment of diseases associated with amyloid or amyloid-like proteins, like e.g. alzheimer's |
| 07/22/2010 | US20100183503 Myocardial perfusion imaging methods and compositions |
| 07/22/2010 | US20100183502 Stabilized Uncoated Particles of Reversed Liquid Crystalline Phase Materials |
| 07/22/2010 | US20100183501 Medical Devices With Nanotextured Titanium Coating |
| 07/22/2010 | DE102009005201A1 Verwendung von Polyphenol-haltigen Pflanzenextrakten zur Behandlung von Adipositas und Diabetes mellitus Typ 2 Use of polyphenol-containing plant extracts for the treatment of obesity and type 2 diabetes mellitus |
| 07/22/2010 | DE102009005193A1 Neue heterocyclische Verbindungen als MetAP-2 Inhibitoren New heterocyclic compounds as MetAP-2 inhibitors |
| 07/22/2010 | CA2843448A1 Methods for improving hepatic and immune function in an animal |
| 07/22/2010 | CA2786715A1 Fused amino pyridines for the treatment of brain tumors |
| 07/22/2010 | CA2758030A1 Malate salt of n-(4-{[6,7-bis(methyloxy)quin0lin-4-yl]oxy}phenyl-n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, and crystalline forms therof for the treatment of cancer |
| 07/22/2010 | CA2751892A1 Benzo [c] phenanthridines as antimicrobial agents |
| 07/22/2010 | CA2751884A1 Transdermal administration of tamsulosin |
| 07/22/2010 | CA2750009A1 Imidazothiazole derivatives having proline ring structure |
| 07/22/2010 | CA2749840A1 Novel eicosanoid derivatives |
| 07/22/2010 | CA2749821A1 Ets-2 biomarkers for fibrotic diseases and uses thereof |
| 07/22/2010 | CA2749783A1 Diagnosis and treatment of autism spectrum disorders |
| 07/22/2010 | CA2749751A1 Compositions for the treatment of gastro-esofageal reflux disease (gerd) |
| 07/22/2010 | CA2749727A1 Process for the preparation of rosuvastatin salts |
| 07/22/2010 | CA2749585A1 Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids |
| 07/22/2010 | CA2749424A1 Method of treating cancer |
| 07/22/2010 | CA2749401A1 Low-concentration nutritional composition |
| 07/22/2010 | CA2749348A1 6-phenyl-ih-imidazo [4, 5-c] pyridine-4-carbonitrile derivatives as cathepsin s and/or cathepsin k inhibitors |
| 07/22/2010 | CA2749248A1 Methods for treating inflammatory disorders using 2,4-pyrimidinediamine compounds |
| 07/22/2010 | CA2749245A1 A formulation for oral transmucosal administration of analgesic and/or antispasmodic molecules |
| 07/22/2010 | CA2749202A1 Synergistic combinations of carotenoids and polyphenols |
| 07/22/2010 | CA2749195A1 Protein kinase c inhibitors and uses thereof |
| 07/22/2010 | CA2749163A1 Methods for screening and compounds that protect against amyloid diseases |
| 07/22/2010 | CA2749157A1 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders |
| 07/22/2010 | CA2749133A1 Compositions and methods for the treatment of throat discomfort |
| 07/22/2010 | CA2749114A1 Heteroatom-containing cyclic compound |
| 07/22/2010 | CA2749101A1 Novel forms of bendamustine free base |
| 07/22/2010 | CA2749051A1 Methods for identifying patients who will respond well to cancer treatment |
| 07/22/2010 | CA2748831A1 Oxadiazole beta carboline derivatives as antidiabetic compounds |
| 07/22/2010 | CA2748394A1 Oxadiazole derivatives as s1p1 receptor agonists |
| 07/22/2010 | CA2747837A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 07/22/2010 | CA2747835A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 07/22/2010 | CA2747752A1 Novel benzenesulfonamides as calcium channel blockers |
| 07/22/2010 | CA2747269A1 Pharmaceutical formulation of nanonised fenofibrate |
| 07/22/2010 | CA2746856A1 Energetic nutritional composition comprising a laxative, electrolytes and carbohydrates |
| 07/22/2010 | CA2729262A1 Fenofibrate formulation with enhanced oral bioavailability |
| 07/21/2010 | EP2209000A2 Detection, monitoring and treatment of cancer |
| 07/21/2010 | EP2208998A2 Polymer conjugate enhanced bioassays |
| 07/21/2010 | EP2208736A2 Endogenous retrovirus up-regulated in prostate cancer |
| 07/21/2010 | EP2208730A1 Polymorphic forms of rifaximin, processes for their production and use thereof in medicinal preparations |
| 07/21/2010 | EP2208729A1 Oxazolidinone derivative having 7-membered hetero ring |
| 07/21/2010 | EP2208728A1 Heterocyclic derivative having inhibitory activity on type-i 11 -hydroxysteroid dehydrogenase |
| 07/21/2010 | EP2208727A1 Diaryl ethers as opioid receptor antagonist |
| 07/21/2010 | EP2208726A1 Cyclic amide derivatives, and their production and use as antithrombotic agents |
| 07/21/2010 | EP2208725A1 Novel specific inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications |
| 07/21/2010 | EP2208721A1 Histone deacetylase inhibitor, composition and use thereof |
| 07/21/2010 | EP2208720A1 Novel eicosanoid derivatives |
| 07/21/2010 | EP2208509A2 Topical compositions combining fragments of sodium hyaluronate and a retinoid |
| 07/21/2010 | EP2208499A1 Nucleic acid capable of regulating the proliferation of cell |
| 07/21/2010 | EP2208498A1 Pharmaceutical composition combining various venotonic and vasoprotective agents for the treatment of chronic venous insufficiency |
| 07/21/2010 | EP2208497A1 Use of Ursodeoxycholic acid (UDCA) for enhancing the general health condition of a tumor patient |
| 07/21/2010 | EP2208496A1 Pharmaceutical formulations of potassium ATP channel openers and uses thereof |
| 07/21/2010 | EP2208495A1 Cyanoguanidine-based azole compounds useful as malonyl-CoA decarboxylase inhibitors |
| 07/21/2010 | EP2208422A1 Compositions and methods for reducing or preventing obesity |
| 07/21/2010 | EP2207819A1 Anti-microbial polymers and their compositions |
| 07/21/2010 | EP2207811A1 Non-anticoagulant polysaccharide compositions |
| 07/21/2010 | EP2207810A1 Compositions affecting hyaluronic acid mediated activity |
| 07/21/2010 | EP2207801A1 Methods of inhibiting viral infection |
| 07/21/2010 | EP2207788A1 Steroidal [3, 2-c]pyrazole compounds, with glucocorticoid activity |
| 07/21/2010 | EP2207787A2 Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties |
| 07/21/2010 | EP2207786A1 2 ' -flu0r0-2 ' -deoxytetrahydrouridines as cytidine deaminase inhibitors |
| 07/21/2010 | EP2207781A1 Thiazolopyrimidine p13k inhibitor compounds and methods of use |
| 07/21/2010 | EP2207780A1 Thienopyrimidine compounds and compositions |
| 07/21/2010 | EP2207779A1 Method of synthesis of morpholino oligomers |
| 07/21/2010 | EP2207777A2 Polymorphs of dasatinib and process for preparation thereof |
| 07/21/2010 | EP2207776A1 Drug active in neuropathic pain |
| 07/21/2010 | EP2207775A1 4-benzylamino-1-carboxyacyl-piperidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis |
| 07/21/2010 | EP2207774A1 Triazole derivatives as scd inhibitors |
| 07/21/2010 | EP2207773A2 Heterocyclic compound and pharmaceutical composition thereof |
| 07/21/2010 | EP2207772A1 Thiophene-2-carboxamide derivatives as modulators of ccr9 receptor |
| 07/21/2010 | EP2207770A1 1, 2, 3-triazole derivatives for use as stearoyl-coa desaturase inhibitors |
| 07/21/2010 | EP2207766A1 Novel sulfamate compounds for medical use |